RUSSELL FRANK CO/ - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 51 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$501,000
-39.1%
36,623
-16.3%
0.00%0.0%
Q4 2015$823,000
-2.1%
43,773
-2.3%
0.00%
-50.0%
Q3 2015$841,000
-41.4%
44,826
-60.6%
0.00%
-33.3%
Q3 2014$1,436,000113,8400.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,149,120$14,559,0002.72%
Corriente Advisors, LLC 680,000$8,595,0002.05%
ACUTA CAPITAL PARTNERS, LLC 537,500$6,794,0001.85%
INGALLS & SNYDER LLC 1,362,203$17,218,0000.85%
Kensington Investment Counsel, LLC 75,533$955,0000.79%
SPHERA FUNDS MANAGEMENT LTD. 384,039$4,854,0000.43%
Opaleye Management Inc. 254,000$3,211,0000.42%
RA Capital Management 1,823,520$23,049,0000.32%
Perceptive Advisors 2,150,641$27,184,0000.29%
Parkman Healthcare Partners LLC 50,290$636,0000.16%
View complete list of CONCERT PHARMACEUTICALS INC shareholders